10 - 13 July | Hamburg, Germany

ISSCR

The world's best and brightest in stem cell research and regenerative medicine convene once a year for the ISSCR Annual Meeting. Join more than 4,000 scientists from around the globe at ISSCR 2023 to take part in a 4-day program comprising the year's most significant new advances in the field.

Conference website

ISSCR

The world's best and brightest in stem cell research and regenerative medicine convene once a year for the ISSCR Annual Meeting. Join more than 4,000 scientists from around the globe at ISSCR 2023 to take part in a 4-day program comprising the year's most significant new advances in the field.

Conference website

Listen to our innovation showcase, view our posters or pop by our booth!

Come and visit our team at our stand #1002 to discuss how bit.bio offers partnering opportunities that affords access to the most relevant parental human cell types and corresponding disease models. These models are physiologically relevant and highly characterised, offering predictive, in vitro, human cells for early drug discovery, phenotypic screening, and high-content imaging applications.

 

Don't miss our innovation showcase talk on "Unlocking the power of deterministic cell programming in biomedical research and drug discovery"in Hall G2, Level 2 | 12pm – 1pm | Thursday, 11 July. Speakers: Roger Pedersen (Stanford University), Matthias Pawlowski (University of Münster), Sejla Salic-Hainzl (bit.bio),. Grab a pretzel and a coffee and listen to our speakers!

 

We will be presenting the following posters on a wide range of our ioCells including ioMicroglia & associated Disease Models, ioSensory Neurons, ioSkeletal Myocytes disease models, CRISPR-Ready Glutamatergic Neurons and CRISPR ioMicroglia:

  • PHYSIOLOGICALLY RELEVANT MEDIA UNMASKS SEVERE MITOCHONDRIAL DYSFUNCTION IN A PRECISION REPROGRAMMED IPSC-DERIVED MODEL OF HUNTINGTON'S DISEASE
    Presented by: Tony Oosterveen | Principal Scientist | bit.bio
    Presentation date: Wednesday July 10
    Poster board number: 502
    Poster Presentation time: 6:45 PM - 7:45 PM
    Track: Disease Modeling and Drug Discovery (DMDD)
  • GENERATION AND FUNCTIONAL CHARACTERISATION OF MOTOR NEURONS DERIVED THROUGH TRANSCRIPTION FACTOR MEDIATED PROGRAMMING OF HUMAN PLURIPOTENT STEM CELLS
    Presented by:  Tom Brown | Senior Product Manager | bit.bio
    Presentation date: Wednesday July 10
    Poster board number: 521
    Poster Presentation time: 5:45 PM - 6:45 PM
    Track: Disease Modeling and Drug Discovery (DMDD)
  • A TOOLBOX OF HUMAN IPSC-DERIVED MICROGLIA IN DIFFERENT GENETIC BACKGROUNDS AND DISEASE MODELS FOR NEURODEGENERATION DRUG DISCOVERY
    Presented by: Ann Byrne | Business Development Manager, Functional Genomics | bit.bio
    Presentation date: Wednesday July 10
    Poster board number: 378
    Poster Presentation time: 6:45 PM - 7:45 PM
    Track: Disease Modeling and Drug Discovery (DMD)
  • SCALABLE IPSC PROGRAMMING STRATEGY IN COMBINATION WITH OPTIMISED COCKTAILS OF NEUROTROPHIC FACTORS YIELDS FUNCTIONALLY DISTINCT NOCICEPTOR SENSORY NEURONS
    Presented by: Roisin Nicoll | Senior Account Manager | bit.bio
    Presentation date: Wednesday July 10
    Poster board number: 525
    Poster Presentation time: 5:45 PM - 6:45 PM
    Track: Disease Modeling and Drug Discovery (DMDD)
  • HARNESSING CRISPR-READY GLUTAMATERGIC NEURONS FOR DRUG DISCOVERY IN NEURODEGENERATIVE DISEASES
    Presented by: Lisa Grabner | Project Lead | bit.bio Discovery
    Presentation date: Wednesday July 10
    Poster board number: 513
    Poster Presentation time: 5:45 PM - 6:45 PM
    Track: Disease Modeling and Drug Discovery (DMDD)
  • ADVANCING DRUG DISCOVERY: LEVERAGING CRISPR-READY MICROGLIA FOR FUNCTIONAL GENOMICS STUDIES
    Presented by: Clara Schmidt | Senior Scientist | bit.bio Discovery
    Presentation date: Wednesday July 10
    Poster board number: 309
    Poster Presentation time: 5:45 PM - : 6:45 PM
    Track: Disease Modeling and Drug Discovery (DMDD)
  • SCALABLE AND WELL DEFINED HUMAN GLUTAMATERGIC AND GABAERGIC CO CULTURE PLATFORM SUITABLE FOR STUDYING EXCITATORY INHIBITORY NEURON IMBALANCES AND THE DISCOVERY OF DRUGS TO TREAT ASSOCIATED DISEASES
    Presented by: Antoinette Krainz | Senior Account Manager | bit.bio
    Presentation date: Wednesday July 10, 2024
    Poster board number: 505
    Poster Presentation time: 5:45 PM - 6:45 PM
    Track: Disease Modeling and Drug Discovery (DMDD)



 

Arrange a meeting

Related pages

News Read our latest updates and press coverage
Blog Learn more about cells, our products, company and culture
About us Find out more about us and our people